Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 3/20 | 0.36 |
| ▸ | TET3 | O43151 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.34 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.34 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1300073 | 0.85 | — | — | |
| SCHEMBL8852391 | 0.83 | CA1 (0.34) | TDP1GRIK1GRIK2GRM1GRM2 | |
| SCHEMBL1949300 | 0.80 | TDP1 (0.38) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL1794769 | 0.80 | CHRM1 (0.48) | TET2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL10952875 | 0.78 | TDP1 (0.32) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL2408287 | 0.78 | — | — | |
| Ethylmalonate SCHEMBL28635933 | 0.77 | HDAC1 (0.41) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL1259560 | 0.77 | HDAC1 (0.44) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL577633 | 0.77 | CA2 (0.48) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5276347 | 0.77 | ALDH1A1 (0.41) | TET2CHRM1AKR1A1CHRM3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290652-A | Novel bio-based ternary polymer and preparation method and application thereof | 南京艾普拉斯化工有限公司 | 2024-07-05 | — | — | CN | claimed |
| US-20200375929-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CANCER, INFLAMMATION, OR IMMUNE RESPONSE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-12-03 | — | — | US | claimed |
| EP-3199560-B1 | MODIFIED POLYVINYL ALCOHOL AND WATER-SOLUBLE FILM | KURARAY CO (JP) | 2020-11-11 | — | — | EP | claimed |
| EP-2459606-B1 | HYBRID COPOLYMER COMPOSITIONS | NOURYON CHEMICALS INT BV (NL) | 2020-10-21 | — | — | EP | claimed |
| EP-3668497-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CANCER, INFLAMMATION, OR IMMUNE RESPONSE | Washington University (US) | 2020-06-24 | — | — | EP | claimed |
| WO-2019036509-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CANCER, INFLAMMATION, OR IMMUNE RESPONSE | WASHINGTON UNIVERSITY (US) | 2019-02-21 | — | — | WO | claimed |
| EP-1346957-B1 | MULTIFONCTIONAL CALCIUM CARBONATE AND CALCIUM PHOSPATE SCALE INHIBITOR | AKZO NOBEL CHEMICALS INT BV (NL) | 2018-08-08 | — | — | EP | claimed |
| EP-2145921-B1 | Vulcanizable polymer compositions | ARLANXEO DEUTSCHLAND GMBH (DE) | 2017-01-25 | — | — | EP | claimed |
| US-9109068-B2 | Hybrid copolymer compositions | AKZO NOBEL N.V. (NL) | 2015-08-18 | — | — | US | claimed |
| EP-2199326-B1 | Vulcanizable polymer compositions | LANXESS DEUTSCHLAND GMBH (DE) | 2014-10-29 | — | — | EP | claimed |
| EP-2459606-A1 | HYBRID COPOLYMER COMPOSITIONS | Akzo Nobel N.V. (NL) | 2012-06-06 | — | — | EP | claimed |
| US-20120128608-A1 | Hybrid copolymer compositions | AKZO NOBEL N.V. (NL) | 2012-05-24 | — | — | US | claimed |
| WO-2011014783-A1 | HYBRID COPOLYMER COMPOSITIONS | AKZO NOBEL N.V. (NL) | 2011-02-03 | — | — | WO | claimed |
| US-20110028371-A1 | HYBRID COPOLYMERS | AKZO NOBEL N.V. (NL) | 2011-02-03 | — | — | US | claimed |
| EP-0397375-B1 | Photosensitive composition and photosensitive lithographic printing plate | KONISHIROKU PHOTO IND (JP) | 1994-04-06 | — | — | EP | claimed |
| EP-0315478-B1 | High-lubricity film | KUREHA CHEMICAL IND CO LTD (JP) | 1994-04-06 | — | — | EP | claimed |
| EP-0361769-B1 | Thermoplastic elastomer composition and rubber parts of refrigerator having a layer composed of thermoplastic elastomer composition | JAPAN SYNTHETIC RUBBER CO LTD (JP) | 1994-03-30 | — | — | EP | claimed |
| EP-0238974-B1 | HEAT RESISTANCE-IMPROVED METAL-POLYPROPYLENE LAMINATE COMPOSITE | Chisso Corporation (JP) | 1991-12-27 | — | — | EP | claimed |
| US-5021523-A | Polymer alloy of polyarylene thioether and a process for producing the same | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-06-04 | — | — | US | claimed |
| EP-0397375-A1 | Photosensitive composition and photosensitive lithographic printing plate | KONICA CORPORATION (JP) | 1990-11-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120128608-A1 | Hybrid copolymer compositions | EPHX2, PUF60, ELOVL6 | TET2 2156/4885TET3 574/4885TET1 461/4885 |
| US-20200375929-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CANCER, INFLAMMATION, OR IMMUNE RESPONSE | IKBKG, IKBKB, NFKBIA | TET2 841/4885TET3 1706/4885TET1 1399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.